A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
Trial ID or NCT#
NCT02815891
Status
RECRUITING
Purpose
TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice. TARGET-NASH is a research registry of patients with NAFL or NASH within academic and community real-world practices maintained in order to assess the safety and effectiveness of current and future therapies.
Official Title
A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
Eligibility Criteria
Ages Eligible for Study: Older than 2 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
- 1. Adults and children (age 2 or older) being managed or treated for nonalcoholic fatty liver disease. Diagnosis is based on the clinical judgement of the care provider.
Exclusion Criteria:
- 1. Inability to provide informed assent/consent.
Investigator(s)
Aijaz Ahmed, MD
Hepatologist,
Transplant hepatologist
Professor of Medicine (Gastroenterology and Hepatology)
Paul Kwo
Hepatologist,
Transplant hepatologist,
Gastroenterologist
Professor of Medicine (Gastroenterology and Hepatology)
Contact us to find out if this trial is right for you.
Contact
Tanvi Chitre
650-722-9651
View on ClinicalTrials.gov
